APA (7th ed.) Citation

B, S., T, F., M, W., M, P., C, B., & L, d. J. (2024). Cost effectiveness of empagliflozin in adult patients with chronic kidney disease in the Netherlands. PloS one, 19(12), e0315509. https://doi.org/10.1371/journal.pone.0315509

Chicago Style (17th ed.) Citation

B, Slob, Fens T, Weersma M, Postma M, Boersma C, and de Jong L. "Cost Effectiveness of Empagliflozin in Adult Patients with Chronic Kidney Disease in the Netherlands." PloS One 19, no. 12 (2024): e0315509. https://doi.org/10.1371/journal.pone.0315509.

MLA (9th ed.) Citation

B, Slob, et al. "Cost Effectiveness of Empagliflozin in Adult Patients with Chronic Kidney Disease in the Netherlands." PloS One, vol. 19, no. 12, 2024, p. e0315509, https://doi.org/10.1371/journal.pone.0315509.